Objective: Many different factors are involved in the pathogenesis of preterm deliveries and among them maternal or perinatal infections and inflammatory response have the major role. Researches were carried out about resistin, which is thought to have a role in inflammatory cytokine cycle and it was shown to be associated with growth in neonates. However, no research has been carried out showing its relationship with inflammation in neonates. In this study, we aimed to evaluate the resistin levels in premature neonates and the effect of events such as preterm prelabour rupture of the membranes (PPROMs) and the use of antenatal steroids on these levels.
Introduction
Many different factors are involved in the pathogenesis of preterm deliveries and among them maternal or perinatal infections and inflammatory response have the major role. 1 Preterm prelabour rupture of the membranes (PPROMs) complicates 30 to 40% of preterm births and has multiple etiologies wherein intra-amniotic infection and inflammation are the major underlying mechanisms and constitute nearly 30% of the cases. 2 Glucocorticosteroids are proved to be potent anti-inflammatory agents and are commonly used in a number of inflammatory conditions as the first-line therapy to suppress the overexpressed inflammatory processes. 3 They are also used antenatally to induce lung maturation and result in a reduced fetal inflammatory response syndrome. 4, 5 Resistin is a recently discovered adipocytokine that belongs to a family of small, cysteine-rich secreted proteins also known as resistin-like molecules that have been implicated in the regulation of inflammatory processes. 6 Although resistin is secreted solely from adipose tissue in rodents, expression levels of the gene encoding resistin is found to be more pronounced in human peripheral blood mononuclear cells than in adipocytes. 7 In peripheral blood mononuclear cells, expression of resistin mRNA is markedly increased by the proinflammatory cytokines, interleukin (IL)-1, IL-6 and tumor necrosis factor, and by lipopolysaccharide. 7, 8 In turn, resistin stimulates the synthesis of the proinflammatory cytokines tumor necrosis factor, IL-1, IL-6 and IL-12 through a nuclear factor (NF)-kB-dependent pathway. 9, 10 Previous studies have shown the role of resistin in inflammation and several inflammatory diseases 6, 11 and it was shown to be associated with growth in neonates. [12] [13] [14] [15] [16] However, no research has been carried out showing its relationship with inflammation in neonates. The objective of this study was to evaluate the resistin levels in premature neonates and the effect of events such as PPROM and the use of antenatal steroids on these levels.
Methods
The study included 118 preterm neonates delivered because of preterm labor, fetal distress or placental pathology, such as placental abruption and placenta previa, and hospitalized in the Neonatal Intensive Care Unit of Zeynep Kamil Maternity and Children's Education and Training Hospital between March and September 2008. All the neonates born between 24 and 34 weeks of gestational age were included in the study. Their medical data together with their mothers' including antenatal steroid administration or PPROM were recorded. The following babies were excluded from the study: (i) the ones with major congenital anomaly; (ii) the ones with chorioamnionitis; (iii) the ones whose mothers had chronic diseases such as insulin-dependent diabetes mellitus; (iv) pregnancy-related diseases such as gestational diabetes and preeclampsia. Venous blood samples for resistin, IL-6, C-reactive protein (CRP), procalcitonin, complete blood count and peripheral blood smear were obtained from a peripheral vein in the first 2 h of life before any medication. The serum was separated at 5000 r.p.m. for 5 min. CRP and procalcitonin levels were evaluated immediately, whereas the separated sera for IL-6 and resistin were kept at À40 1C at most for 3 months until the laboratory evaluation.
Biochemical assays CRP levels were quantitatively evaluated by nephelometric method with a cardio PHASE hsCRP kit (Dade Behring, Marburg GMBH, Germany) on the Nephelometer (Siemans, Dade Behring, BN II Nephelometer, Marburg, Germany) and the results were expressed as milligram per liter. Procalcitonin levels were analyzed by chemiluminescence method by a procalcitonin kit (BRAHMS Diagnostica, Berlin, Germany) on the Liaison analyzer (Diasorin s.p.A., Saluggia (Vercelli), Italy) and the results were expressed as nanogram per milliliter. Nucleated red blood cell counts were expressed per 100 white blood cells. Plasma resistin levels were measured using a commercially available micro ELISA kit (Linco Research, St Charles, MO, USA) according to the manufacturer's instructions. IL-6 concentrations were determined using commercial ELISA kit (Biosource International, Camarillo, CA, USA).
Statistical analysis
Data were expressed as mean±s.d. for normally distributed continuous variables or median (min-max values) for skewed continuous variables and as proportions for categorical variables.
A P-value <0.05 was considered as statistically significant. Statistically significant differences were analyzed between groups by Mann-Whitney U-test. Correlations were analyzed by Spearman's correlation test.
The study was approved by the local ethics committee. Informed consents were obtained from the families of the infants included in the study.
Results
In all, 118 neonates with gestational ages <34 weeks were included in the study. Mean birth weight of the babies was 1306.4±393.4 g and mean gestational age was 29.6±2.7 weeks. In all, 49.2% (n ¼ 58) of the babies were female. Mean maternal age was 26 ± 5.1 years and median parity was 2 (range: 1 to 6) years. Resistin, IL-6, procalcitonin, CRP and normoblast levels are given in Table 1 . There was no correlation between resistin levels and birth weight or gestational age of the neonates (r ¼ À0.1, P ¼ 0.2; and r ¼ À0.03, P ¼ 0.8). No difference was observed between resistin levels of male and female neonates (24.1 (6.9 to 159.9) ng ml -1 and 33.9 (5.5 to 568.4) ng ml -1 respectively). Sixty-seven (56.8%) of the babies were delivered with labor. There was no difference in resistin levels of babies delivered with or without labor (28.2 (7.8 to 568.4) ng ml -1 and 28.4 (5.5 to 529) ng ml -1 ; P ¼ 0.32). Thirty-two (27.1%) babies were delivered because of fetal distress and 19 (16.1%) were delivered because of placental pathology such as abruptio placentae or placenta previa. Sixty-five (55.1%) of the babies were delivered from mothers who had received antibiotics. There was no difference in resistin levels of babies delivered from mothers who had received antibiotics or not (30.7 (5.5 to 568.4) ng ml -1 and 23.3 (7.4 to 529) ng ml -1 ; P ¼ 0.52). Abbreviations: CRP, C-reactive protein; IL-6, interleukin-6.
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Forty-four of the babies received antenatal steroids, whereas data were missing for eight of the babies. The babies of mothers who had received antenatal steroids had significantly lower resistin levels than the babies of mothers who had not (P ¼ 0.015) ( Table 2 ). However, there was no difference in IL-6, CRP, procalcitonin and normoblast levels of these babies (Table 2 ). There were significant correlations between IL-6 and resistin, (r ¼ 0.27, P ¼ 0.03), procalcitonin (r ¼ 0.36, P ¼ 0.004), CRP (r ¼ 0.43, P ¼ 0.000) and normoblast (r ¼ 0.31, P ¼ 0.012) levels in babies whose mothers did not receive antenatal steroids. However, no correlation was found between these parameters in babies whose mothers received antenatal steroids.
Babies with PPROM had significantly higher levels of resistin ((n ¼ 30); 70.7 (7.8 to 568.4) ng ml -1 ) than the babies without PPROM ((n ¼ 88); 25.9 (5.5 to 528.9) ng ml -1 ) (P ¼ 0.005) ( Table 3) . No difference was observed in the IL-6, CRP, procalcitonin and normoblast levels of these babies (Table 3) . There was no correlation between resistin levels and other parameters of the babies with PPROM or without PPROM. As the cutoff used to consider a fetus as having a fetal inflammatory response syndrome is >11 pg ml -1 , resistin levels of babies with IL-6 levels higher (n ¼ 71) and lower than 11 pg ml -1 (n ¼ 46) were compared and no difference was found between these levels (IL-6 p11 pg ml -1 ; 21.7 ng ml -1 (5.5 to 529), IL-6 >11 pg ml -1 32.8 (5.5 to 568.4) ng ml -1 ; P ¼ 0.07). None of the mothers or the babies included in the study had clinical findings of inflammation or infection, such as fever, uterine tenderness and early-onset neonatal sepsis. However, as we did not have the histological examination of the placenta or the cord and the vessels, intraamniotic inflammation could not be ruled out.
Forty-six (39%) of the babies had respiratory distress syndrome; 13.5% (n ¼ 16) had hypotension; 16.1% (n ¼ 19) had patent ductus arteriosus; 2.4% (n ¼ 3) had necrotizing enterocolitis; 5% (n ¼ 8) had intraventricular hemorrhage; 12.7% (n ¼ 15) had bronchopulmonary dysplasia; 20.3% (n ¼ 24) had retinopathy of prematurity; and 18.6% (n ¼ 22) died. There was no association between the resistin levels and morbidity and mortality of the babies.
Discussion
There are several studies carried out in neonates evaluating the relationship between resistin levels and other adipokines and anthropometric parameters. [12] [13] [14] [15] [16] Resistin was suggested to be involved in the maintenance of neonatal metabolic homeostasis. 15 Its levels in neonates changed between 8 and 21 ng ml -1 , 12, 15, 17 and were reported to be higher than maternal levels. 15, 18 It was also detected in amniotic fluid starting from the 14th week of gestation in which levels increased with advancing gestational age and at term the levels reached to 23.6 ng ml -1 . 19 However, there are conflicting results about the relationship between resistin levels and gestational age of the neonates. No correlation was observed between umbilical cord blood resistin levels and gestational age of the neonates, 14 whereas positive correlation was observed between the resistin levels obtained within the first 2 h of life and gestational age in one study, 12 and in the study of Martos-Moreno et al., 16 preterm neonates had higher resistin levels than full-term neonates. The levels were found to be similar in infants with intrauterine growth retardation and appropriate for gestational age (AGA) infants. 18, 20 Placental resistin gene expression was not different between small for gestational age and AGA infants. 21 The levels were found to be positively correlated with birth weight in some studies 12, 14 and negatively correlated with birth weight in another study. 15 However, in others no correlation was found. [16] [17] [18] 20, 21 In our study, no correlation was found between resistin levels and gestational age or birth weight of the babies. Median resistin levels (28.3 ng ml -1 ) of our study is somewhat higher than the levels (8 to 21 ng ml -1 ) reported in previous studies, such as the levels of IL-6 (20.5 pg ml -1 ) for which the cutoff value to consider a fetus as having a fetal inflammatory response syndrome was determined to be >11 pg ml -1 . However, all the babies included in this study are premature babies and so we can speculate that the inflammation (though could not be proved in this study) that may have resulted in preterm delivery in these babies might be the reason of these higher observed levels.
Resistin is secreted in appreciable quantities by mononuclear cells and so it is suggested to be involved in inflammatory conditions. 22 Patients with severe inflammation had significantly higher resistin levels when compared with healthy individuals. 8 Levels were found to be correlated with other inflammatory markers in patients with inflammation. 8, 22 CRP was also reported to be correlated with resistin levels in several pathological conditions. 23 Lipopolysaccharides were reported to induce resistin gene expression in macrophages, and in human peripheral blood mononuclear cells, resistin induce IL-6 and tumor necrosis factora through NF-kB. [6] [7] [8] [9] [10] In this study, resistin levels were higher in Abbreviations: CRP, C-reactive protein; IL-6, interleukin-6; PPROM, preterm prelabour rupture of the membrane.
Resistin levels in preterms and inflammation T Gursoy et al neonates who had PPROM than the ones without PPROM, but no difference was observed in IL-6 levels between these two groups. Pathophysiology of PPROM is multifactorial, including inflammation. PPROM in turn is associated with a local inflammatory and a counter anti-inflammatory response in the chorioamniotic membranes and causes release of cytokines and inflammation. 2 Cytokines induce resistin secretion. Amniotic fluid resistin levels were found to be higher in cases with intra-amniotic infection and cutoff level of 37 ng ml -1 had a sensitivity of 85.4% and a specificity of 94.3% for the diagnosis of intraamniotic inflammation. 19 In this study, median resistin levels (70.7 ng ml -1 ) of babies with PPROM were significantly higher than the babies without PPROM (25.9 ng ml -1 ) and levels were comparable with the study of Kusanovic et al., 19 which was a case-control study wherein the cutoff value for resistin was 37 ng ml -1 , although it was a level for the amniotic fluid. Increased levels of resistin in neonates with PPROM might be the result of inflammation observed in these babies. However, levels of other inflammatory markers such as IL-6, CRP and procalcitonin were not increased in neonates with PPROM and no correlation was observed between resistin levels and these markers. This may be due to the lack of clinical chorioamnionitis and early-onset sepsis in our babies in whom IL-6 levels were mostly reported to be elevated. Nevertheless, further studies are required to determine these levels in babies with infection or chorioamnionitis.
Forty-four (37.3%) of the babies received antenatal steroids, whereas data were missing for eight of the babies. This low percentage of antenatal steroid usage in our group was due to the low socioeconomic status of our population. Most of the mothers did not have antenatal follow-up and were referred to our hospital just before birth. The babies of mothers who received antenatal steroids had significantly lower resistin levels than the babies of mothers who did not and there were significant correlations between resistin and IL-6 levels and between IL-6, procalcitonin, CRP and normoblast levels in babies whose mothers did not receive antenatal steroids. However, no correlation was found between these parameters in babies whose mothers received antenatal steroids. Endogenous glucocorticoids downregulate the expression and action of the cytokines in the body. 1 Likewise, steroids administered antenatally results in a reduced fetal inflammatory response. Steroids act through glucocorticoid receptors and decrease levels of inflammatory proteins by downregulating NF-kB and activating protein. 4 Disappearance of all the correlations observed in the babies whose mothers did not receive steroids may be due to the potent anti-inflammatory effects of steroids.
NF-kB is an essential transcription factor for the expression of inflammatory proteins. Resistin activates NF-kB directly and dose dependently and has potent proinflammatory properties. 10 Resistin is also secreted from the placenta and dexamethasone decreased the release of resistin from the placenta. 24 This may also explain the lower resistin levels observed in neonates who have received antenatal steroid.
Preterm delivery and PPROM involves complex cascade of events including inflammation, and steroids are potent antiinflammatory agents. Elevated resistin levels in babies with PPROM and suppressed levels in babies whose mothers received antenatal steroids reported in this study might have been observed as a result of the effects of fetal inflammation on resistin levels.
